Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from China Isotope & Radiation Corp. ( (HK:1763) ).
China Isotope & Radiation Corporation announced that its subsidiary Anhui Young-Hearty Medical Appliance & Equipment has secured a Class II Medical Device Registration Certificate in China for a self-developed Red Blood Cell Lifespan Measurement Breath Analyzer. The approval allows commercial launch and expands the company’s breath diagnostics portfolio beyond Helicobacter pylori testing into hematology-focused applications.
The analyzer measures endogenous carbon monoxide in exhaled breath to calculate red blood cell lifespan, enabling non-invasive, rapid testing that can support diagnosis of anaemia and haemolysis, differential diagnosis of jaundice, and assessment of treatment efficacy in hematological diseases. By integrating testing, data management and equipment maintenance in a single platform, the device is designed to enhance clinical efficiency and operational stability, potentially strengthening the company’s positioning in advanced diagnostic technologies and offering new tools to hospitals and specialists in hematology and related disciplines.
The most recent analyst rating on (HK:1763) stock is a Buy with a HK$26.00 price target. To see the full list of analyst forecasts on China Isotope & Radiation Corp. stock, see the HK:1763 Stock Forecast page.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation is a PRC-based joint stock company focused on medical and nuclear-related technologies, including diagnostic solutions leveraging breath testing. Through subsidiaries such as Anhui Young-Hearty Medical Appliance & Equipment and Zhonghe Headway, the group develops and markets medical devices aimed at improving clinical diagnostics and patient management in hospital settings.
Average Trading Volume: 199,011
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.62B
See more insights into 1763 stock on TipRanks’ Stock Analysis page.